Just listened to the BP Dr Been interview. Another revenue stream ("indication" for ohm20's list could be anti-aging/wellness since Leronlimab quiets inflammations in general, which takes away from internal stress. Moreover it prevents cancer from metastasizing and especially here time is crucial, so the earlier the better. Lots of people would be willing to take Leronlimab on a monthly basis just for prophylactical reasons.
I wonder if regularly Leronlimab intake might save cancer treatment costs in general, because in lots of cases people get treated long time after the cancer started doing its thing. And even if the costs would be almost identical the benefits would be unmeasurable. I could imagine insurance companies paying part of the costs in combination with some anti cancer tax and everyone would still get away cheaper than before. Then again this will never happen, but one is allowed to have dreams.